MEDICAID RESTRICTIVE DRUG FORMULARIES PROPOSAL
MEDICARE RESTRICTIVE DRUG FORMULARIES PROPOSAL will be the topic of a hearing by Rep. Waxman (D-Calif.) scheduled for April 1 before the House Energy and Commerce/Health Subcommittee. The hearing will address a Clinton Administration proposal to permit states to establish restrictive drug formularies under Medicaid. A provision in the 1990 Medicaid rebate law (OBRA '90) prohibited state formularies. Scheduled witnesses include: the Pharmaceutical Manufacturers Association, the National Governors Association, Kaiser Commission on the Future of Medicaid Chairman James Tallon and representatives of state legislatures, county health departments and the American Association of Homes for the Aging.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth